tiprankstipranks
Trending News
More News >
Quinsam Capital Corporation (TSE:QCA)
:QCA

Quinsam Capital (QCA) AI Stock Analysis

Compare
10 Followers

Top Page

TSE:QCA

Quinsam Capital

(QCA)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
C$0.05
▼(-10.00% Downside)
The score is held back primarily by weak financial performance (recurring losses and recent cash burn) despite a supportive, debt-free balance sheet. Technical signals are largely neutral, and valuation is constrained by negative earnings. The earnings call adds moderate upside potential via expected listings and NAV improvement, but notable execution and regulatory/transaction risks remain.
Positive Factors
Debt-free balance sheet
Quinsam's zero total debt is a durable structural strength: it reduces solvency risk, preserves strategic optionality, and allows the firm to deploy capital or withstand portfolio drawdowns without immediate refinancing. This supports long-term survival while pursuing opportunistic investments.
Potential NAV uplift from listings
Planned listings for Peninsula (Renterz) and Electro Metals represent structural catalysts: successful IPOs would crystallize private asset values, improve portfolio liquidity, and sustainably raise NAV. Realized listings can materially shift long-term capital base and reduce valuation opacity.
Clinical-trial progress for A-Synaptic
Regulatory approval for a clinical trial and a material grant indicate substantive de-risking and external validation for A-Synaptic. As a portfolio company, successful clinical outcomes or milestone achievements would deliver durable value creation and potential material upside to Quinsam's investment realizations.
Negative Factors
Recurring net losses
Sustained multi-year net losses erode equity and reduce internal capital available for reinvestment. For an investment holding company without operating revenue, persistent losses increase dependency on successful exits or external funding and heighten the long-term risk to shareholder capital.
Negative operating cash flow
Recent cash burn reduces financial flexibility: negative operating and free cash flows force reliance on portfolio monetizations or financings. Without recurring operating income, ongoing negative cash flow over months could necessitate dilutive raises or asset sales, undermining long-term strategy execution.
Execution & regulatory transaction risk
Cease-trade events and tax complications on potential deals are structural execution risks for a merchant bank. Such regulatory or transactional impediments can delay value realization, depress valuations of holdings, and add uncertainty to NAV recovery timelines, affecting long-term returns.

Quinsam Capital (QCA) vs. iShares MSCI Canada ETF (EWC)

Quinsam Capital Business Overview & Revenue Model

Company DescriptionQuinsam Capital Corporation operates as a merchant banking firm in small-cap market in Canada. It primarily focuses on investments in technology, healthcare, mining exploration, e-sports, and cannabis markets. The company's activities include acquisitions, advisory services, lending activities, and portfolio investments. Quinsam Capital Corporation was incorporated in 2004 and is based in Toronto, Canada.
How the Company Makes MoneyQuinsam Capital makes money through a diversified revenue model primarily centered around investment income. The company generates revenue by deploying capital into public and private equity investments and realizing gains when these investments appreciate in value. Key revenue streams include dividends, interest income from debt investments, and capital gains from the sale of equity positions. Quinsam Capital's earnings are influenced by its ability to identify profitable investment opportunities and effectively manage its investment portfolio. Partnerships with emerging growth companies and strategic investments in high-potential sectors also contribute to its financial performance.

Quinsam Capital Earnings Call Summary

Earnings Call Date:Dec 01, 2025
(Q3-2025)
|
Next Earnings Date:May 04, 2026
Earnings Call Sentiment Neutral
The earnings call presents a cautiously optimistic outlook for Q4, with significant potential gains from private investments going public and successful developments in medical trials. However, challenges such as the Newlox Gold cease trade and complications with a potential transaction introduce some uncertainty.
Q3-2025 Updates
Positive Updates
Private Investments Going Public
Two private investments, Peninsula (now Renterz) and Electro Metals, are looking to go public in Q4. Peninsula is a U.S. single-family rental business trying to raise funds at $1.90 per share, and Electro Metals is a traditional Canadian mining company focused on copper and gold, awaiting final listing approval.
Successful CBD Treatment Trials
A-Synaptic, a company developing CBD treatment for epilepsy, has been approved by the FDA for a clinical trial at Boston's Children's Hospital. Additionally, a $3 million grant from the Michael J. Fox Foundation is funding a trial for using the same treatment for Parkinson's.
Positive Outlook for Q4
Expectations for a profitable Q4 are supported by potential gains from private investments going public and improvement in the valuation of companies like Newlox Gold, which is expected to resume trading at $0.05-$0.06 per share.
Negative Updates
Newlox Gold Cease Trade
Newlox Gold is currently under a cease trade due to late financials, leading to a conservative valuation of 0 in Q3. However, it was trading around $0.05-$0.06 before the halt.
Complications with Potential Transaction
A promising transaction with an American-based company faces income tax complications for main shareholders, which are delaying the deal.
Company Guidance
During the Quinsam third-quarter conference call, Roger Dent highlighted key developments expected in Q4, including two private investments set to list: Peninsula, a U.S. single-family rental business aiming to raise funds at $1.90 under the name Renterz, and Electro Metals, a copper and gold mining company awaiting final exchange approval. These listings could enhance the net asset value (NAV) from $0.06 to $0.08, with further potential growth. He also mentioned A-Synaptic, which is developing a CBD treatment for epilepsy and Parkinson's, backed by a $3 million grant from the Michael J. Fox Foundation. Additionally, Newlox Gold, currently under a cease trade, is expected to resume trading at approximately $0.05-$0.06. Dent expressed optimism for a profitable Q4 despite market volatility, with potential transactions involving an American-based cash flow-positive company under consideration, contingent on resolving tax complications.

Quinsam Capital Financial Statement Overview

Summary
Overall fundamentals are weak due to recurring net losses and a recent shift back to negative operating cash flow/free cash flow, which has contributed to equity erosion. The main offsetting positive is a debt-free balance sheet with positive equity, reducing solvency risk despite ongoing volatility.
Income Statement
18
Very Negative
Profitability has deteriorated meaningfully: TTM (Trailing-Twelve-Months) shows negative revenue and a sizable net loss (net income -4.2M), following net losses in each of the last four annual periods (2021–2024). While the reported revenue growth rate is very high in TTM, results remain loss-making and earnings have been volatile over time (including an exceptionally large loss in 2022). The main strength is that losses have not been accompanied by financial leverage, but operating performance is currently weak.
Balance Sheet
62
Positive
The balance sheet is a relative bright spot: total debt is 0 in TTM (Trailing-Twelve-Months) and recent annual periods, resulting in no leverage pressure. Equity remains positive (~9.2M in TTM), and assets are broadly stable versus equity (assets ~9.25M). The key weakness is persistent negative returns on equity (TTM ROE about -46%), and equity has trended down from 2021–2023 levels, indicating capital erosion from ongoing losses.
Cash Flow
28
Negative
Cash generation has weakened: TTM (Trailing-Twelve-Months) operating cash flow and free cash flow are both negative (~-0.4M), following a negative 2024 and a positive 2022–2023. A positive is that free cash flow has closely tracked reported earnings (free cash flow to net income ~1.0), suggesting limited non-cash distortions; however, cash burn in the most recent periods reduces financial flexibility and increases reliance on portfolio outcomes or financing alternatives if it persists.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue-4.95M-1.90M-7.39M-1.54M-1.20M3.10M
Gross Profit-5.16M-2.13M-7.63M-1.78M-1.42M2.73M
EBITDA-4.20M-2.98M-2.92M-16.18M-2.11M2.16M
Net Income-4.20M-3.02M-2.02M-15.52M-2.48M2.44M
Balance Sheet
Total Assets9.25M9.26M12.40M14.85M31.93M34.83M
Cash, Cash Equivalents and Short-Term Investments365.04K313.23K1.18M855.37K58.38K32.87M
Total Debt0.000.000.000.0086.28K0.00
Total Liabilities74.61K125.69K158.35K279.80K1.18M659.45K
Stockholders Equity9.17M9.13M12.24M14.57M30.75M34.17M
Cash Flow
Free Cash Flow-400.66K-472.08K326.98K1.51M347.54K1.81M
Operating Cash Flow-400.66K-472.08K326.98K1.51M347.54K1.81M
Investing Cash Flow326.05K-211.95K324.31K2.25M-86.86K0.00
Financing Cash Flow-120.10K-181.91K-327.48K-717.54K-1.40M-1.37M

Quinsam Capital Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.05
Price Trends
50DMA
0.05
Negative
100DMA
0.05
Negative
200DMA
0.05
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
34.20
Neutral
STOCH
16.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:QCA, the sentiment is Negative. The current price of 0.05 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 34.20 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:QCA.

Quinsam Capital Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
C$8.81M0.5675.06%486.23%478.94%
66
Neutral
C$6.60M3.3942.23%7.52%-54.61%273.14%
56
Neutral
C$4.02M-0.35-178.43%82.65%-70.88%
51
Neutral
C$8.01M-0.32-55.73%53.55%-289.42%
48
Neutral
C$4.68M-0.98-37.19%26.42%-1217.14%
42
Neutral
C$4.13M-0.59-226.11%19.82%-51.61%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:QCA
Quinsam Capital
0.05
-0.02
-25.00%
TSE:AAB
Aberdeen International
0.03
>-0.01
-24.24%
TSE:BLGV
Belgravia Capital International Inc
0.03
-0.03
-58.33%
TSE:IDK
ThreeD Capital
0.09
-0.09
-50.00%
TSE:PDV
Prime Dividend Cl A
11.66
4.68
67.19%
TSE:ZC
Zimtu Capital
0.69
0.54
363.09%

Quinsam Capital Corporate Events

Business Operations and StrategyFinancial Disclosures
Quinsam Capital Reports Decreased Q3 Earnings, Optimistic About Q4
Neutral
Nov 13, 2025

Quinsam Capital Corporation reported a net income of $0.1 million for Q3 2025, a decrease from $1.2 million in Q3 2024. The company remains optimistic about Q4 due to potential public listings of two major investments, Peninsula (RentX) and Electro Metals, which could be funded at levels above their carrying values. Despite a flat performance in the summer, Quinsam notes an increase in trading prices for several investments and continues to trade at a discount from its net asset value. The company is searching for a value-creating transaction and has not repurchased any shares in its current issuer bid.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025